These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 12003383

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
    Wisnoski NC, Townsend CM, Nealon WH, Freeman JL, Riall TS.
    Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
    [Abstract] [Full Text] [Related]

  • 5. Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: long-term survival analysis.
    Sarmiento JM, Farnell MB, Que FG, Nagorney DM.
    World J Surg; 2002 Oct; 26(10):1267-71. PubMed ID: 12205558
    [Abstract] [Full Text] [Related]

  • 6. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
    Fendrich V, Habbe N, Celik I, Langer P, Zielke A, Bartsch DK, Rothmund M.
    Dtsch Med Wochenschr; 2007 Feb 02; 132(5):195-200. PubMed ID: 17252361
    [Abstract] [Full Text] [Related]

  • 7. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
    Yeh TS, Cheng AJ, Chen TC, Jan YY, Hwang TL, Jeng LB, Chen MF, Wang TC.
    J Surg Res; 1999 Dec 02; 87(2):171-7. PubMed ID: 10600346
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acinar cell carcinoma of the pancreas: is the absence of neuroendocrine component related to a more malignant behavior?
    Machado MC, Machado MA, Perini MV, Herman P, Jukemura J, Leite KR, Bacchella T.
    Hepatogastroenterology; 2008 Dec 02; 55(82-83):708-10. PubMed ID: 18613439
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study.
    Gullo L, Migliori M, Falconi M, Pederzoli P, Bettini R, Casadei R, Delle Fave G, Corleto VD, Ceccarelli C, Santini D, Tomassetti P.
    Am J Gastroenterol; 2003 Nov 02; 98(11):2435-9. PubMed ID: 14638345
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
    Stelow EB, Shaco-Levy R, Bao F, Garcia J, Klimstra DS.
    Am J Surg Pathol; 2010 Apr 02; 34(4):510-8. PubMed ID: 20182344
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours.
    La Rosa S, Rigoli E, Uccella S, Novario R, Capella C.
    Histopathology; 2007 Apr 02; 50(5):597-606. PubMed ID: 17394496
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.